Abstract Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, was isolated from the culture broth of Streptomyces sp. K04-0144 by Diaion HP-20 and ODS column chromatographies and preparative HPLC. The structure of cyslabdan was elucidated by spectroscopic analyses including NMR. The compound has a labdane-type diterpene skeleton connecting with an N-acetylcysteine via thioether linkage.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is known as a major nosocomial pathogen which has also developed resistance to many other antibiotics [1] . Moreover, MRSA getting resistant to the last-resort antibiotic, vancomycin, has been reported [2, 3] . These facts suggest that MRSA would acquire more resistance to vancomycin in the near future. It is therefore increasingly important and necessary to find new antimicrobial agents and to devise new measures that are effective against MRSA infection.
Based on the new concept of "anti-infective drugs" developed by Ō mura [4] , a screening system was established to search for microbial potentiators of imipenem activity against MRSA, and new stemphones were recently discovered from the culture broth of Aspergillus sp. FKI-2136 [5] . During our continuous screening program, an actinomycete strain K04-0144 was found to produce a strong potentiator of imipenem activity against MRSA. Activity-guided purification lead to the discovery of a novel compound designated cyslabdan (Fig. 1) . From the structural elucidation, the fundamental skeleton of cyslabdan is similar to that of totarol previously presented as a b -lactam potentiator [6] . As described in detail in the accompanying paper [7] , cyslabdan showed almost no anti-MRSA activity by itself (MIC, 64 m g/ml), but the compound (10 m g/ml, no activity against MRSA) enhanced the imipenem activity against MRSA over 1,000 folds, indicating that clinically resistant MRSA strains become clinically susceptible in the presence of cyslabdan.
In this study, the taxonomy of the producing strain, fermentation, isolation, and structural elucidation of cyslabdan are described.
Materials and Methods

General Experimental Procedures
Strain K04-0144 was isolated from a soil sample collected at Ishigakijima Island, Okinawa, Japan, and was used for production of cyslabdan. For determination of the amount of cyslabdan in culture broths, the samples dissolved in MeOH were analyzed by HP1100 system (HewlettPackard) under the following conditions: column, Symmetry (2.1ϫ150 mm, Waters Inc.); flow rate, 0.2 ml/minute; mobile phase, a 20-minute linear gradient from 5.0% CH 3 CN / 0.05% H 3 PO 4 to 100% CH 3 CN / 0.05% H 3 PO 4 ; detection, UV at 210 nm. The peak of cyslabdan was eluted with a retention time of 17.4 minutes.
UV spectra were recorded on a spectrophotometer (DU640, Beckman). IR spectra were recorded on a Fourier transform infrared spectrometer (FT-710, Horiba). Optical rotations were measured with a digital polarimeter (DIP-370, JASCO). FAB-MS spectra and HR-FAB-MS spectra were recorded on a mass spectrometer (JMS-AX505HA, JEOL). The various NMR spectra were collected with a spectrometer (XL-400, Varian).
Taxonomic Studies
The International Streptomyces Project (ISP) media recommended by Shirling and Gottlieb [8] and media recommended by Waksman [9] were used to investigate the cultural and physiological characteristics. Cultures were routinely observed after the incubation for two weeks at 27°C. Color names and hue numbers were determined according to the Color Harmony Manual [10] . The utilization of carbon sources was tested by growth on Pridham and Gottlieb's medium containing 1.0% carbon at 27°C [11] . The morphological properties were observed with a scanning electron microscope (model JSM-5600, JEOL). The type of diaminopimelic acid (DAP) isomers was determined by the method of Becker et al. [12] . Menaquinones were extracted and purified by the method of Collins et al. [13] , then were analyzed by HPLC (Gulliver System, JASCO) equipped with a Capcell Pak C18 column (4.6ϫ250 mm, Shiseido) [15] . 
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Taxonomy of the Producing Strain
The vegetative mycelia grew abundantly on yeast extractmalt extract agar, inorganic salts -starch agar and others, and did not show fragmentation into coccoid forms or bacillary elements. The color of vegetative mycelia showed pale yellow. The aerial mycelia grew abundantly on yeast extract -malt extract and glycerol -asparagine agar and the aerial mass color showed white to gray. From observation of the scanning electron micrograph of the strain (Fig. 2) , the spore chains were spiral and each had more than 20 spores per chain. The spores were cylindrical in shape, 1.0ϫ1.0ϳ1.2 mm in size and had a smooth surface. Whirls, sclerotic granules, sporangia and flagellate spores were not observed. Growth temperature range was 12°C to 42°C. DGlucose, D-mannitol, melibiose and L-rhamnose were used well, and L-arabinose, D-fructose, myo-inositol, raffinose, sucrose and D-xylose were used slightly as sole carbon. Melanoid pigment and other soluble pigments were not produced. Hydrolysis of starch was positive, and coagulation and peptonization of milk were positive.
The isomer of DAP in whole-cell hydrolysates of strain K04-0144 was determined to be LL-form. Major menaquinones were MK-9 (H 6 ) and MK-9 (H 8 ).
Based on the taxonomic properties described above, strain K04-0144 (NITE BP-107) is considered to belong to the genus Streptomyces [14] .
Fermentation
A slant culture of the strain K04-0144 grown on the slant medium (starch 1.0%, N-Z-amine 0.3%, yeast extract 0.02%, meat extract 0.1%, CaCO 3 0.3%, agar 1.2%, pH 7.0) was used to inoculate five 500-ml Erlenmeyer flasks each containing 100 ml of the seed medium (starch 2.4%, glucose 0.1%, peptone 0.3%, yeast extract 0.5%, CaCO 3 0.4%, pH 6.0). The flasks were shaken on a rotary shaker at 27°C for 3 days. The seed culture (500 ml) was transferred into a 90-liter jar fermenter containing 50 liters of the production medium (glucose 0.5%, corn steep powder 0.5%, oatmeal 1.0%, Pharmamedia 1.0%, K 2 HPO 4 0.5%, Fig. 3 . The production of cyslabdan was observed at day 1 after inoculation, and reached a maximum (2.3 mg/ml) at day 5.
Isolation
The 6-day old culture broth (50 liters) was centrifuged to separate the mycelium and supernatant. The supernatant was applied on a Diaion HP-20 column (100ϫ200 mm, Mitsubishi Chemical. Co.). After washing with H 2 O, active principles were eluted with MeOH and concentrated in vacuo to dryness to yield brown oily materials (32 g). The materials were dissolved in H 2 O, and undesired materials were removed by extraction with EtOAc. The H 2 O layer was concentrated to yield brown materials (27 g). A half of the materials were dissolved in a small volume of H 2 O and applied on an ODS column (50ϫ280 mm). Materials were eluted stepwise with 40, 60, 80 and 100% MeOH (4.0 liters each). The 80% MeOH fraction showing the activity was concentrated to give brown materials (134 mg). The materials were finally purified by HPLC (column, PEGASIL ODS (Senshu Scientific. Co.) 20ϫ250 mm; mobile phase, 60% CH 3 CN containing 0.05% H 3 PO 4 ; flow rate, 8.0 ml/minute; detection, UV at 210 nm). Under these conditions, cyslabdan was eluted as a peak with a retention time of 32 minutes. The fraction was applied on a Diaion HP-20 column to remove H 3 PO 4 . After washing with H 2 O, cyslabdan was eluted with MeOH and concentrated to yield a white powder (17 mg).
Structural Elucidation
Physico-chemical properties of cyslabdan are summarized in Table 1 . The IR absorption at 3427 cm Ϫ1 suggested the presence of a hydroxy residue in the structure. The molecular formula was determined as C 25 H 41 NO 5 S on the basis of HRFAB-MS measurement. The 13 C-NMR spectrum showed 25 resolved peaks, which are classified into five methyl carbons, eight methylene carbons, four sp At the indicated times, whole culture broth (10 ml) was removed from the flask, and centrifuged at 3,000 rpm. The pH of the supernatant and packed cell volume (PCV, ml) were measured. The amount of cyslabdan was determined by HPLC as described in Materials and Methods. ᭜; pH, ; PCV, ᭡; production. Configuration NOE experiments suggested the relative configuration of the diterpene part (Fig. 6) ) indicated the configuration of C-8 and C-9. Thus, the relative configuration of the labdane skeleton was shown to be (12E)-labda-12,14-dien-7b ,8a -diol.
To elucidate the configuration of N-acetylcysteine, cyslabdan was degraded as described in Materials and Methods. Under the HPLC conditions, the retention times of the authentic N-acetyl-L-alanine and N-acetyl-D-alanine were 9.25 and 10.57 minutes, respectively. Since the obtained N-acetylalanine was eluted with the retention time of 9.25 minutes, it was identified as N-acetyl-L-alanine. Therefore, the absolute configuration of N-acetylcysteine part of cyslabdan was elucidated as L-form.
Discussion
In this study, cyslabdan was isolated from the streptomycete metabolites, and the structure was elucidated to be a labdane-type diterpene skeleton connecting with an N-acetylcysteine via thioether likage. Furthermore the relative configuration of the labdane part and the absolute configuration of the N-acetylcysteine part were demonstrated. By comparison with the structure of plant labdane diterpenoids [20ϳ23], the total absolute configuration of cyslabdan was suggested as shown in Fig. 1 . However, there are two different parts of the stereochemistry between actinomycete cyslabdan and plant labdanes; 1) regarding the double bond at C-12, cyslabdan has 12E-configuration, while some plant labadanes have 12Z-configuration [20] , and 2) regarding the hydroxy moiety at C-7, cyslabdan and nidorellol from plants Nidorella spp. show 7S configuration, while the labdane isolated from liverwort Porella perrottetiana shows 7R [22, 23] . Labdane diterpenoids had been isolated only from plant metabolites. Therefore, cyslabdane is the first actinomycete metabolite having a labdane-type diterpene structure.
Moreover, cyslabdan has a thioether-linked N-acetyl-L-cysteine moiety. Several compounds having an Nacetylcysteine of actinomycete orgin have been reported, and their configurations are all L-form as well as cyslabdan [24, 25] .
Cyslabdan was found to strongly enhance the b-lactam imipenem activity against MRSA. The potentiation indicates that clinically resistant MRSA strains become clinically susceptible in the presence of cyslabdan. The biological activity of cyslabdan will be described in detail in the accompanying study. 
